Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant EpilepsiesPRNewsWire • 08/22/24
Wall Street Analysts Believe Jazz (JAZZ) Could Rally 56.66%: Here's is How to TradeZacks Investment Research • 08/06/24
Investing in Jazz (JAZZ)? Don't Miss Assessing Its International Revenue TrendsZacks Investment Research • 08/05/24
Jazz Pharmaceuticals (JAZZ) Beats Q2 Earnings and Revenue EstimatesZacks Investment Research • 07/31/24
Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial GuidancePRNewsWire • 07/31/24
Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General MeetingPRNewsWire • 07/25/24
Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026PRNewsWire • 07/22/24
If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 NamesInvestorPlace • 07/19/24
Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024PRNewsWire • 07/17/24
Is The Options Market Predicting A Spike In JAZZ Pharmaceuticals (JAZZ) Stock?Zacks Investment Research • 07/11/24